Blood Cancer

Showing NaN - NaN of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

Terminated
  • Non-Hodgkin's B-cell Lymphoma
  • +5 more
  • MT-3724 Phase 1
  • MT-3724 Phase 2
  • Tucson, Arizona
  • +40 more
Jul 18, 2022

IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)

Recruiting
  • IDH Mutation
  • +4 more
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021